IGF2 and Hypoglycemia: The partial display of hypoglycemic symptoms among patients with IGF-II-secreting tumors reported in the literature is compliant with the possibility that the tissue concentration of IGF-II required to sustain autocrine tumorigenic signals may be several orders lower compared to those needed to trigger generalized hypoglycemia.